ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 240 participants.
Also called NCT05225961
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 240 participants
- Sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- Registry
-
NCT05225961
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT05225961. Randomized; single masking; primary purpose treatment. Start 2026-03-20 (actual); primary completion 2026-03-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion
- Acronym
- ATILA
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Tirofiban
- Intervention (Drug)
- Acetylsalicylic acid
- Lead sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Record details
- Record id
cardio:ct-nct05225961- Content hash
5b21418d97f6c0395d8e7d8543f9ebb969633d44742045cb0c01112bf7273fe3